Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1976-03-19
1977-09-13
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
424270, 424273R, 424273P, A61K 3141
Patent
active
040483193
ABSTRACT:
A method of inhibiting histamine activity, in particular inhibiting H-2 histamine receptors, by administering heterocyclicalkylguanidines.
REFERENCES:
patent: 3736331 (1973-05-01), Black et al.
patent: 3818097 (1974-06-01), Black et al.
patent: 3868457 (1975-02-01), Black et al.
patent: 3950333 (1976-04-01), Durant et al.
patent: 3968216 (1976-07-01), Black et al.
Black James Whyte
Durant Graham John
Emmett John Colin
Ganellin Charon Robin
Drezin Norman A.
Edgerton William H.
Foggio Richard D.
Keps Joan S.
Smith Kline & French Laboratories Limited
LandOfFree
Method of inhibiting histamine activity with quanidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting histamine activity with quanidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting histamine activity with quanidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-274697